Science & Research
Scinai Immunotherapeutics Ltd. Highlights PC111 Breakthrough Following Top Italian Dermatology Award
Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) celebrates Dr. Roberta Lotti's award-winning research on PC111, a promising treatment for pemphigus vulgaris, underscoring its potential as a non-immunosuppressive therapy for autoimmune skin conditions.
Annovis Bio Inc. to Showcase Alzheimer’s Research at AAIC 2025
Annovis Bio Inc. will present significant advancements in Alzheimer’s treatment at the Alzheimer’s Association International Conference 2025, highlighting the potential of its lead candidate, buntanetap.
Emperor Metals Inc. Identifies Dual Gold Trends at Duquesne West Property
Emperor Metals Inc. and Globex Mining Enterprises Inc. have identified two high-grade gold mineralization trends at the Duquesne West Property in Quebec, signaling potential for a new resource calculation.
Growing Public Interest in Mitochondrial Function Testing Highlights Advances in Health and Longevity
The increasing public interest in mitochondrial health testing underscores significant advancements in addressing mitochondrial dysfunction and its implications for overall wellness and longevity.
NeuroSense Therapeutics Advances Toward Canadian Fast-Track Approval for ALS Drug PrimeC
NeuroSense Therapeutics' progress with Health Canada for its ALS drug PrimeC could accelerate approval and bolster a significant pharmaceutical partnership, highlighting a pivotal moment for ALS treatment and the biotech sector.
BiomX Inc.: A Biotech Pioneer with Pentagon Backing and Promising Phage Therapy
BiomX Inc. (NYSE: PHGE), a biotech company with a market cap of $13 million, has secured $40 million in non-dilutive funding from the U.S. Defense Health Agency, highlighting its potential in addressing antibiotic-resistant infections with phage therapy.
ABVC BioPharma CEO Recognized Among Influential Indian-Origin CEOs in Global Biotech
Dr. Uttam Patil, CEO of ABVC BioPharma, is highlighted for his leadership in advancing a novel botanical antidepressant, ABV-1504, which could revolutionize treatment for Major Depressive Disorder by eliminating suicidal ideation side effects.
Foremost Clean Energy Ltd. Initiates Radon Survey at Wolverine Uranium Site to Identify High-Grade Deposits
Foremost Clean Energy Ltd. has commenced a radon geochemical survey at its Wolverine Uranium Property in the Athabasca Basin, aiming to refine subsurface models and pinpoint drill targets for uranium exploration.
New Scanning Method Research Funded to Improve Brain Tumor Treatment
Researchers from NHS Grampian and the University of Aberdeen receive funding to explore a novel scanning method that could enhance the treatment of aggressive brain tumors, specifically glioblastomas.
GeoVax Secures Patent for Innovative Malaria Vaccine Design
GeoVax Labs, Inc. has been granted a U.S. patent for a novel vaccine construct aimed at preventing malaria, marking a significant step forward in the fight against the disease and other infectious threats.
Shift in Heart Disease Deaths Highlights Advances and Emerging Challenges
Over the past 50 years, heart disease death rates have significantly decreased, with a shift from heart attacks to heart failure, arrhythmias, and hypertensive heart disease, reflecting medical advancements and emerging health challenges.
Creative Biolabs Enhances Neuroscience Research with Cutting-Edge Electrophysiology and Electrode Chip Technologies
Creative Biolabs introduces advanced electrophysiology and electrode chip technologies to significantly impact neuroscience research, offering new avenues for understanding neuronal activity and developing neurotherapeutics.
D-Wave Quantum Inc. Partners with Yonsei University and Incheon City to Boost Quantum Computing in South Korea
D-Wave Quantum Inc. collaborates with Yonsei University and Incheon City to enhance quantum computing research and commercialization in South Korea, marking a significant step in the region's quantum infrastructure development.
InMed Pharmaceuticals Reports Promising Preclinical Results for Alzheimer's Treatment
InMed Pharmaceuticals Inc. announces positive preclinical results for INM-901, showing potential in reducing neuroinflammation associated with Alzheimer's disease, independent of amyloid beta or tau pathology.
Fermented Wheat Germ Could Enhance Immunotherapy Outcomes for Cancer Patients
A clinical trial at UC Davis is exploring the potential of fermented wheat germ to improve immunotherapy results for cancer patients, offering hope for better survival rates and quality of life.
CNS Pharmaceuticals Inc. Sheds Light on GBM Treatment Advances in KOL Segment
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) explores the potential of its lead product candidate, TPI 287, in treating Glioblastoma Multiforme (GBM) and future metastatic tumor indications, as discussed by Dr. Erin Dunbar in a recent Virtual Investor KOL Connect segment.
BioUtah Supports National Life Sciences Workforce Collaborative to Strengthen Talent Pipelines
BioUtah's investment in the Life Sciences Workforce Collaborative highlights Utah's commitment to developing a skilled workforce for its rapidly growing life sciences sector.
Axim Biotechnologies Seeks FDA CLIA Waiver for Lactoferrin Diagnostic Test
Axim Biotechnologies has taken a significant step towards broadening access to its Lactoferrin diagnostic test by filing a Pre-Submission with the FDA for a CLIA Waiver, aiming to facilitate easier diagnosis and monitoring of Aqueous Deficient Dry Eye Disease.
FDA Approval of Keytruda® in Head and Neck Cancer Highlights Potential for Gedeptin® Combination Therapy
The FDA's approval of Keytruda® for head and neck cancer treatment underscores the therapeutic potential of combining it with GeoVax’s Gedeptin®, aiming to enhance tumor clearance and reduce relapse rates.
Study Shows Multiple Doses of Extracellular Vesicles Could Reduce Lung Injury Risk in ICU Patients
A new study by Leksum LLC suggests that multiple doses of extracellular vesicles may significantly improve diaphragm muscle function in mechanically ventilated ICU patients, potentially reducing the risk of lung injury and improving recovery outcomes.
Medicus Pharma Ltd. Develops Novel Non-Invasive Treatment for Basal Cell Carcinoma
Medicus Pharma Ltd. is advancing a revolutionary, non-invasive microneedle patch treatment for basal cell carcinoma, potentially transforming the $15 billion skin cancer treatment market.
Creative Biolabs Advances Liposome Technology for Enhanced Drug Delivery
Creative Biolabs is pioneering liposome technology to improve drug delivery systems, offering innovative solutions for pharmaceutical industries and beyond.
Creative Biolabs Advances mRNA Therapeutics with Comprehensive Solutions
Creative Biolabs is enhancing the development of mRNA therapies, offering innovative solutions that address key challenges in stability, delivery, and scalability, pivotal for treatments ranging from HIV to cancer.
Global Study Highlights Growing Mismatch in Ecosystem Services Supply and Demand
A comprehensive global study reveals alarming deficits in carbon sequestration and water yield, driven by climate change and human activities, underscoring the urgent need for targeted conservation strategies.
Study Reveals Viability of Ambient Temperature Transport for Human Oocytes, Opening New Research Avenues
A groundbreaking study demonstrates that human oocytes can be transported at ambient temperature without losing viability, offering new opportunities for research in reproductive medicine and stem cell therapy.
Research Reveals Why Most Smokers Avoid Lung Cancer Despite Tobacco Use
A new study explains the biological mechanisms that protect most smokers from developing lung cancer, offering insights into prevention and treatment strategies.
Lexaria Bioscience Corp. Achieves Global Patent Milestone with 50 Patents
Lexaria Bioscience Corp. has reached a significant milestone with 50 patents granted worldwide, including new patents for epilepsy treatment and sublingual nicotine delivery, marking a pivotal moment in the company's strategy to expand its drug delivery platform.
Michael Schwob Highlights the Science of Sound on Las Vegas Morning Blend
Acoustics expert Michael Schwob discusses the impact of sound design on health and productivity in built environments during a recent television appearance.
Creative Biolabs Expands Skincare Innovation with Multi-source Exosome Research Line
Creative Biolabs introduces a groundbreaking multi-source exosome skincare research line, offering new avenues for anti-aging and regenerative skincare solutions.
Scientist Calls for Transparency in Scientific Funding and Innovation to Save Lives and Taxpayer Money
Dario Crosetto, an Italian-American scientist, challenges the scientific establishment for transparency and accountability in funding, highlighting the potential of his 3D-CBS invention to revolutionize cancer detection and reduce healthcare costs.